Healthcare & Life Sciences Insights

Discover Latham’s latest insights into the commercial, regulatory, and legal developments shaping the global healthcare and life sciences landscape.

Latham’s cross-disciplinary team delivers insightful, practical guidance and sophisticated representation to a full spectrum of healthcare and life sciences companies across the globe, on every type of transaction or dispute a company may face.

Learn more about our capabilities

In The Spotlight

US State Regulatory Spotlight on Healthcare Transactions: Reflections From 2024

Shiny transparent capsule filled with colorful spheres

October 21, 2024 Podcast

Episode 86 — Drug Pricing: Takeaways From the Chicago Medicaid Drug Rebate Program Summit

Close up of Asian women with hi tech digital technology screen over the eye.

May 30, 2024 Webcast

US Regulators’ Joint Inquiry Into Healthcare Consolidation: Navigating the New Landscape

April 30, 2024 Client Alert

US Regulators Announce Inquiry Into Healthcare Consolidation

April 11, 2024 Resource

Healthcare & Life Sciences Market Update

Genetic research, conceptual image. DNA (deoxyribonucleic acid) autoradiogram in a petri dish.

November 14, 2024 Webcast

Patents and Trade Secrets in Life Sciences: What to Know About Protecting Your IP Innovations

Latham’s Healthcare & Life Sciences and IP Litigation practitioners discuss protecting patent and trade secrets in life sciences. MCLE credits offered.

October 30, 2024 Webcast

FDA Life Sciences Enforcement Update: Recent Trends and a Look Ahead

Latham’s Healthcare & Life Sciences practitioners discuss recent trends in FDA enforcement activities and what to expect in the coming year. MCLE credit offered.

October 21, 2024 Podcast

Episode 86 — Drug Pricing: Takeaways From the Chicago Medicaid Drug Rebate Program Summit

October 18, 2024 Client Alert

US State Regulatory Spotlight on Healthcare Transactions: Reflections From 2024

October 8, 2024 Client Alert

Middle District of Florida Accepts Justice Thomas’s Invitation: FCA Qui Tam Provision Unconstitutional

October 21, 2024

Episode 86 — Drug Pricing: Takeaways From the Chicago Medicaid Drug Rebate Program Summit

One of the year’s major drug pricing conferences just concluded in Chicago. Join the Latham team to discuss takeaways from the conference, including highlights from remarks by government speakers.

September 19, 2024

The Demise of Chevron Deference and Its Impact on the Healthcare and Life Sciences Industries

Latham lawyers discuss the implications of the US Supreme Court decision in Loper Bright. MCLE credit offered.

Episode 85 Drug Pricing How Demise Chevron Deference and Other Litigation May Impact Pharma Industry

September 19, 2024

Episode 85 — Drug Pricing: How the Demise of Chevron Deference and Other Litigation May Impact the Pharmaceutical Industry

Recent Supreme Court decisions, such as those overruling Chevron deference, as well as ongoing manufacturer challenges to the Inflation Reduction Act and state 340B laws, will likely have a significant impact on the pharmaceutical industry.

August 19, 2024

Episode 83 — Drug Pricing: How Are Payers Responding to the IRA?

Explore how health insurance companies are adapting to the Inflation Reduction Act's new requirements, including the Part D redesign.

June 21, 2024

Episode 82 — Drug Pricing: Takeaways From the New Orleans Pricing and Contracting USA Conference

One of the year’s major drug pricing conferences just concluded in New Orleans. Join the Latham team to discuss takeaways from the conference, with topics including 340B developments, state legislative activity, and IRA implementation.

June 13, 2024

Episode 81 — Drug Pricing: A Look Behind the Curtain of the New ASP Reporting Website and Other Data Collection Portals

The new ASP reporting website highlights the increasing significance of data collection portals — and yet the number of permitted users is very small. Join us as we learn from leading practitioners at Riparian how to navigate the complex web of compliance requirements.

May 30, 2024

US Regulators’ Joint Inquiry Into Healthcare Consolidation: Navigating the New Landscape

Latham’s healthcare enforcement and antitrust practitioners discuss how companies can navigate the complexities of healthcare consolidation and regulatory compliance. MCLE credit offered.

March 06, 2024

Next Generation of Nicotine: Center for Tobacco Products — 2024 Outlook

Latham’s FDA Regulatory lawyers discuss CTP’s 2024 agenda for tobacco and nicotine products. MCLE credit offered.

February 21, 2024

2024 FDA Outlook: Healthcare & Life Sciences

Latham’s Healthcare & Life Sciences lawyers discuss FDA’s regulatory and legislative agenda for 2024. MCLE credit offered.

February 01, 2024

Episode 71 — Drug Pricing: A Look Ahead at Trends for 2024

Listen to this “lightning round” to hear how the policy and regulatory environment will likely remain hostile for pharmaceutical manufacturers, and how to address the turbulence that lies ahead.

January 25, 2024

Episode 68 — Drug Pricing: Will Agencies Exercise March-In Rights Based on Drug Price?

A new proposal seeks to reinvigorate the Bayh-Dole Act by allowing government to consider price as a factor when electing to exercise march-in rights.

Our Archive

November 1, 2024 In the News

Latham Partner Brings Clerk Lessons to Hospital Pay Case

Partner Melissa Sherry spoke to Law360 Healthcare Authority about how she applies lessons learned from clerking and her time in the solicitor general's office to her Supreme Court arguments.

Drop of clear blue liquid from droper droping to test tube in laboratory with bright color blur background.

October 31, 2024 Our Work

Latham Advises Harmony Biosciences Holdings, Inc. in Public Offering of Common Stock by Selling Shareholders

Firm represents the pharmaceutical company in the offering.

October 31, 2024 Our Work

Latham & Watkins Advises Leeds Equity Partners in Acquisition of Archer Review

October 30, 2024 Our Work

Latham & Watkins Advises PROCEPT BioRobotics on Offering of Common Stock

October 30, 2024 Our Work

Latham & Watkins Advises PL Developments on Successful Corporate Debt Refinancing

October 23, 2024 Recognition

MVP: Mandy Reeves

Managing Partner of Latham’s Washington, D.C. office and former Global Co-Chair of the firm’s Antitrust & Competition Practice, Mandy Reeves earned MVP recognition from Law360 for her stellar year leading blockbuster merger clearances, antitrust trial teams, and complex anticompetitive conduct investigations for her clients.

October 18, 2024 Recognition

Distinguished Leader Award Winner: Michele Johnson

Global Chair of the Litigation & Trial Department honored for her inspirational leadership and industry-leading practice.

October 15, 2024 Recognition

Latham Recognized for Investigations Excellence by Global Investigations Review

Firm named a finalist for Most Impressive Investigations Practice of the Year, and partner Manny Abascal named a finalist for Investigations Professional of the Year.